1
|
Archibald ME, Behrman P, Yakoby J. Racial-ethnic disparities across substance use disorder treatment settings: Sources of treatment insurance, socioeconomic correlates and clinical features. J Ethn Subst Abuse 2022:1-25. [PMID: 36208872 DOI: 10.1080/15332640.2022.2129537] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/10/2022]
Abstract
Aim: Contrary to expectations, studies of racial-ethnic disparities in substance use disorder (SUD) treatment frequently uncover minority-majority parity in access and utilization of services. What accounts for the anomaly? To answer the question, this study explores racial-ethnic differences in the odds of utilization of SUD treatment in varied settings (e.g., the criminal justice system, private doctor's office, etc.), adjusting for sources of treatment insurance, socioeconomic correlates of treatment (e.g., employment, income, education), as well as clients' clinical features (e.g., type of substance abuse/dependence, co-morbidities, health status). Methods: Data were compiled from the National Survey of Drug Use and Health (NSDUH) dataset, 2002-2014. The sample consisted of respondents with a past year diagnosis of a substance use disorder, who also reported having received treatment (n = 6,207). Data were pooled to maximize subgroup analyses. Weight- and design- adjusted logistic regressions were use to analyze factors predicting SUD treatment source. Results: Blacks were more likely than Whites to receive treatment through the criminal justice system and Whites more likely than Blacks and Latinx to receive treatment at a doctor's office. Blacks were also more likely than Whites to receive treatment through inpatient/outpatient rehabilitation, before adjustments but not afterwards. Discussion: In this study we show that even after adjusting for mechanisms expected to shape pathways from race-ethnicity to SUD treatment sites, significant racial-ethnic disparities persist. This fills an important gap in the literature in that disparities research has not explicitly modeled racial-ethnic variation across the full range of SUD treatment sites.
Collapse
|
2
|
Ritter A, Hull P, Berends L, Chalmers J, Lancaster K. A conceptual schema for government purchasing arrangements for Australian alcohol and other drug treatment. Addict Behav 2016; 60:228-34. [PMID: 27174218 DOI: 10.1016/j.addbeh.2016.04.017] [Citation(s) in RCA: 5] [Impact Index Per Article: 0.6] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 11/10/2015] [Revised: 03/15/2016] [Accepted: 04/20/2016] [Indexed: 11/26/2022]
Abstract
AIM The aim of this study was to establish a conceptual schema for government purchasing of alcohol and other drug treatment in Australia which could encompass the diversity and variety in purchasing arrangements, and facilitate better decision-maker by purchasers. There is a limited evidence base on purchasing arrangements in alcohol and drug treatment despite the clear impact of purchasing arrangements on both treatment processes and treatment outcomes. METHODS The relevant health and social welfare literature on purchasing arrangements was reviewed; data were collected from Australian purchasers and providers of treatment giving detailed descriptions of the array of purchasing arrangements. Combined analysis of the literature and the Australian purchasing data resulted in a draft schema which was then reviewed by an expert committee and subsequently finalised. RESULTS The conceptual schema presented here was purpose-built for alcohol and other drug treatment, with its overlap between health and social welfare services. It has three dimensions: 1. The ways in which providers are chosen; 2. The ways in which services are paid for; and 3. How price is managed. Distinguishing between the methods for choosing providers (such as competitive or individually negotiated processes) from the way in which organisations are paid for their provision of treatment (such as via a block grant or payment for activity) provides conceptual clarity and enables closer analysis of each mechanism. CONCLUSIONS Governments can improve health and wellbeing by making informed decisions about the way they purchase and fund alcohol and other drug treatment. Research comparing different purchasing arrangements can provide a vital evidence-base to inform funders; however a first step is to accurately and consistently categorise current approaches against a typology or conceptual schema.
Collapse
|
3
|
Schmidt EM, Gupta S, Bowe T, Ellerbe LS, Phelps TE, Finney JW, Asch SM, Humphreys K, Trafton J, Vanneman M, Harris AHS. Predictive validity of a quality measure for intensive substance use disorder treatment. Subst Abus 2016; 38:317-323. [PMID: 27435754 DOI: 10.1080/08897077.2016.1212779] [Citation(s) in RCA: 7] [Impact Index Per Article: 0.9] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 10/21/2022]
Abstract
BACKGROUND Measures of substance use disorder (SUD) treatment quality are essential tools for performance improvement. The Veterans Health Administration (VHA) developed a measure of access to and engagement in intensive outpatient programs (IOPs) for SUD. However, predictive validity, or associations between this measure and treatment outcomes, has not been examined. METHODS Data on veterans with SUD came from 3 samples: the Outcomes Monitoring Project (N = 5436), a national evaluation of VHA mental health services (N = 339,887), and patients receiving detoxification services (N = 23,572). Propensity score-weighted mixed-effects regressions modeled associations between receiving at least 1 week of IOP treatment and patient outcomes, controlling for facility-level performance and a random effect for facility. RESULTS Propensity score weighting reduced or eliminated observable baseline differences between patient groups. Patients who accessed IOPs versus those who did not reported significantly reduced alcohol- and drug-related symptom severity, with significantly fewer past-month days drinking alcohol (b = 1.83, P < .001) and fewer past-month days intoxicated (b = 1.55, P < .001). Patients who received IOP after detoxification services had higher 6-month utilization of SUD outpatient visits (b = 2.09, P < .001), more subsequent detoxification episodes (b = 0.25, P < .001), and lower odds of 2-year mortality (odds ratio [OR] = 0.68, 95% confidence interval [CI]: 0.61-0.75; P < .001). CONCLUSIONS Receiving at least 1 week of SUD treatment in an IOP was associated with higher follow-up utilization, improved health outcomes, and reduced mortality. These associations lend support to the predictive validity of VHA's IOP quality measure. Future research should focus on measure feasibility and validity outside of VHA, and whether predictive validity is maintained once this quality measure is tied to performance incentives.
Collapse
Affiliation(s)
- Eric M Schmidt
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA.,b Center for Health Policy/Primary Care and Outcomes Research (CHP/PCOR) and the Division of General Medical Disciplines , Stanford , California , USA
| | - Shalini Gupta
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Thomas Bowe
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Laura S Ellerbe
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Tyler E Phelps
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - John W Finney
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Steven M Asch
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Keith Humphreys
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Jodie Trafton
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA.,c Program Evaluation and Resource Center , Office of Mental Health Operations, VA Palo Alto Health Care System , Menlo Park , California , USA
| | - Megan Vanneman
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA.,b Center for Health Policy/Primary Care and Outcomes Research (CHP/PCOR) and the Division of General Medical Disciplines , Stanford , California , USA
| | - Alex H S Harris
- a Center for Innovation to Implementation (Ci2i) , VA Palo Alto Health Care System , Menlo Park , California , USA
| |
Collapse
|
4
|
Archibald ME, Putnam Rankin C. A spatial analysis of community disadvantage and access to healthcare services in the U.S. Soc Sci Med 2013; 90:11-23. [PMID: 23746604 DOI: 10.1016/j.socscimed.2013.04.023] [Citation(s) in RCA: 16] [Impact Index Per Article: 1.5] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 05/23/2012] [Revised: 03/28/2013] [Accepted: 04/21/2013] [Indexed: 11/29/2022]
Abstract
Ongoing socioeconomic and racial and ethnic gaps in access to healthcare make it vital to examine the relationship between characteristics of communities and their impact on the availability of healthcare services. This study investigates how community-based resource constraints influence the provision of healthcare services in the United States. Drawing on several theoretical frameworks including research in the spatial distribution of healthcare, we compile data on 3141 U.S. counties in order to investigate the argument that gaps in the provision of substance abuse treatment are a function of resource constraints experienced by disadvantaged communities. Our principal aim is to demonstrate that socioeconomic privation, racial and ethnic isolation and limited healthcare infrastructure constrain the provision of substance abuse treatment services. Since prior research shows spatial clustering of socioeconomic privation, racial and ethnic isolation, and healthcare resources, we explicitly model the spatial dimensions of community-based resource disadvantage. Central findings support our chief expectations: counties with greater socioeconomic privation and diminished healthcare infrastructure experienced limited access to substance abuse treatment. Moreover, treatment clusters themselves were significantly related to socioeconomic privation and diminished healthcare infrastructure. Counties with a higher proportion of racial and ethnic minority members, however, did not experience less access to substance abuse treatment, with one exception, although post hoc analyses showed poverty had a moderating effect on race and ethnicity. Study limitations and implications for the organization of treatment resources are discussed.
Collapse
|
5
|
Schwarz R, Zelenev A, Bruce RD, Altice FL. Retention on buprenorphine treatment reduces emergency department utilization, but not hospitalization, among treatment-seeking patients with opioid dependence. J Subst Abuse Treat 2012; 43:451-7. [PMID: 22534003 PMCID: PMC3419304 DOI: 10.1016/j.jsat.2012.03.008] [Citation(s) in RCA: 51] [Impact Index Per Article: 4.3] [Reference Citation Analysis] [Abstract] [Key Words] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/23/2011] [Revised: 03/15/2012] [Accepted: 03/19/2012] [Indexed: 11/22/2022]
Abstract
Drug users are marginalized from typical primary care, often resulting in emergency department (ED) usage and hospitalization due to late-stage disease. Though data suggest methadone decreases such fragmented healthcare utilization (HCU), the impact of buprenorphine maintenance treatment (BMT) on HCU is unknown. Chart review was conducted on opioid dependent patients seeking BMT, comparing individuals (n=59) who left BMT≤7days with those retained on BMT (n=150), for ED use and hospitalization. Using negative binomial regressions, including comparison of time before BMT induction, ED utilization and hospitalization were assessed. Overall, ED utilization was 0.93 events per person year and was significantly reduced by BMT, with increasing time (retention) on BMT. BMT had no significant effect on hospitalizations or average length of stay.
Collapse
Affiliation(s)
- Ryan Schwarz
- Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA
| | | | | | | |
Collapse
|